Method of treatment of parkinson's disease

Details Method of treatment of parkinson's disease Method of treatment of parkinson's disease

1996-09-05

1998-05-26

Spivack, Phyllis G.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

A61K 31165

Patent

active

057565503

ABSTRACT:
2-Amino-N-(1,2-diphenyl-1-methylethyl) acetamide (remacemide), or a pharmaceutically acceptable salt thereof, for use in the treatment of Parkinson's disease is disclosed.

REFERENCES:
Klockgether et al. "NMDA Antagonists potentiate. . ." Annals of Neurology, vol. 28 No. 4, 1990, pp. 539-546.
R. Griffith et al. "Preclinical Neuroprotective . . ." Abstracts of Papers of the American Chemical Society, vol. 201, No. 1-2, 1991, p. 22.
R.V. Eller et al. "Remacemide and L-Dopa . . ." Soc. Neurosci. Abstract, vol. 18 No. 1-2, 1992, p. 1080.
Remington. Pharmaceutical Sciences, 15th Ed. Mack Pub. Co., 1995, pp. 855-857-858.

Affiliated with

Also associated with

Rating

Method of treatment of parkinson's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treatment of parkinson's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treatment of parkinson's disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1960864